9 More Devices Get Class II Status From US FDA
Executive Summary
The newly classified devices include innovative products from Medtronic, Canary Medical and AppliedVR, among others.
You may also be interested in...
FDA Announces Class II Status For 6 New Device Types
The newly classified devices were initially authorized via the de novo pathway.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.